The American Journal of Medicine
Volume 76, Issue 6 , Pages 1113-1117 , June 1984

Focal renal cortical necrosis associated with zomepirac

  • Riad Darwish, M.D.

      Affiliations

    • From the Department of Medicine, University of California, Irvine, California.
    • ,
  • Nosratola D. Vaziri, M.D.

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Dr. N. D. Vaziri, Room C351, Medical Science I, Division of Nephrology, Department of Medicine, University of California, Irvine, California 92717.
    • From the Department of Medicine, University of California, Irvine, California.
    • ,
  • Sudhir Gupta, M.D.

      Affiliations

    • From the Department of Medicine, University of California, Irvine, California.
    • ,
  • Harold Novey, M.D.

      Affiliations

    • From the Department of Medicine, University of California, Irvine, California.
    • ,
  • Gerald S. Spear, M.D.

      Affiliations

    • From the Department of Medicine, University of California, Irvine, California.
    • ,
  • Kendrick Licorish, M.D.

      Affiliations

    • From the Department of Medicine, University of California, Irvine, California.
    • ,
  • David Powers, M.D.

      Affiliations

    • From the Department of Medicine, University of California, Irvine, California.
    • ,
  • Thomas Cesario, M.D.

      Affiliations

    • From the Department of Medicine, University of California, Irvine, California.

,Accepted 11 July 1983.

References 

  1. McCarthy JT, Schwartz GL, Blair TJ, Pierides AM, Van den Berg CJ. Reversible nonoliguric acute renal failure associated with zomepirac therapy. In: 2nd ed. Mayo Clin Proc. 57:1982;p. 351–354
  2. Smith VT. Anaphylactic shock, acute renal failure and disseminated intravascular coagulation—suspected complications of zomepirac. JAMA. 1982;247:1172–1173
  3. Ratner SJ. Zomepirac and renal failure (letter). Ann Intern Med. 1982;96:793
  4. Cannarzzi DB, Wardlow SC, McPhedran P. An improved turbidometric method for plasma fibrinogen. Am J Med Technol. 1977;43:211–215
  5. Gupta S. T cell subpopulations defined with monoclonal antibodies in patients with primary immunodeficiency. Immunol Lett. 1982;4:124–133
  6. Cunningham-Rundles S, Hansen JA, Dupont B. Lymphocyte transformation to mitogens and antigens. In: 2nd ed.  Bach FH,  Good RA editor. Clinical immunology. vol 3:New York: Academic Press; 1978;p. 151–194
  7. Wide L, Bennich H, Johansson SGO. Diagnosis of allergy by in-vitro test for allergen antibodies. Lancet. 1967;II:1105–1106
  8. Nitsche JF, Tucker ES, Sugimoto S, Vaughan JH, Curd JG. Rocket immunoelectrophoresis of C4 and C4d. A simple sensitive method for detecting complement activation in plasma. Am J Clin Pathol. 1981;76:679–684
  9. Henrich WL, Blachley JD. Acute renal failure witth prostaglandin inhibitors. In: 2nd ed. Semin Nephrol. 1:1981;p. 57–60
  10. Sheehan HL, Moore HC. Renal cortical necrosis and the kidney of concealed accidental hemorrhage. Oxford: Blackwell; 1952;
  11. Sheehan HL, Davis JC. Renal ischemia with failed reflow. J Pathol Bacteriol. 1959;78:105–120
  12. Schneider CL. Etiology of fibrinopenia: fibrination defibrination. Ann NY Acad Sci. 1959;75:634
  13. Heptinstall RH. Recovery from cortical necrosis. In:  Heptinstall RH editors. Pathology of the kidney. 2nd ed. Boston: Little, Brown; 1974;p. 246–247
  14. Samuel SA. Apparent anaphylactic reaction to zomepirac (letter). N Engl J Med. 1981;16:304
  15. Corre KA, Rothstein RJ. Anaphylactic reaction to zomepirac. Ann Allergy. 1982;48:299–301
  16. Cuerrero MM. Anaphylaxis following zomepirac ingestion (letter). West J Med. 1983;138:576

PII: 0002-9343(84)90867-2

The American Journal of Medicine
Volume 76, Issue 6 , Pages 1113-1117 , June 1984

Article Tools